Romiplostim mitigates dose‐limiting thrombocytopenia of erucic acid for adrenomyeloneuropathy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|171|5|879-881

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.171, Iss.5, 2015-12, pp. : 879-881

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of eltrombopag after romiplostim in primary immune thrombocytopenia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 1, 2015-04 ,pp. : 111-116

John Wiley & Sons Inc

Access to resources Recommend Favorite

Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity

By  

Acta Haematologica, Vol. 134, Iss. 4, 2015-0 ,pp. : 215-228

Karger

Access to resources Recommend Favorite

Erucic acid rapeseed: 1. Prospects of improvements

By Sanyal Anushree   Pinochet Xavier   Merrien André   Laustriat Marie   Decocq Guillaume   Fine Frédéric  

OCL (Oilseeds, Crops, fats & Lipids), Vol. 22, Iss. 3, 2015-05 ,pp. : D303-D303

Edp Sciences

Access to resources Recommend Favorite

Extensive cerebral venous sinus thrombosis after romiplostim treatment for immune thrombocytopenia (ITP) despite severe thrombocytopenia

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 6, 2015-06 ,pp. : 682-683

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of self‐administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 169-176

John Wiley & Sons Inc

Access to resources Recommend Favorite